Aimei Health Technology Co Right
AFJKR
15 hedge funds and large institutions have $2.19M invested in Aimei Health Technology Co Right in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.
191% more capital invested
Capital invested by funds: $753K → $2.19M (+$1.44M)
0% more funds holding
Funds holding: 15 → 15 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$13.8K |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$16.7K |
| 2 |
Walleye Trading
New York
|
-$11.2K |
| 3 |
GCL
Glazer Capital LLC
New York
|
-$2.75K |
| 4 |
CS
Clear Street
New York
|
-$671 |
| 5 |
HCI
Harraden Circle Investments
New York
|
-$481 |
AFJKR Hedge Fund Activity: Q1 2025 in Review
15 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Aimei Health Technology Co Right (AFJKR) for Q1 2025, worth a combined $2.19M — up 191% from $753K a quarter earlier.
Fund positioning in AFJKR was balanced in Q1 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 5 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $13.8K. The largest seller was Shaolin Capital Management, cutting an estimated $16.7K.
- 15 institutional investors held Aimei Health Technology Co Right (AFJKR) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $2.19M of Aimei Health Technology Co Right stock for Q1 2025, up 191% quarter-over-quarter.
- 1 fund opened new Aimei Health Technology Co Right positions in Q1 2025 and 1 closed out, a net change of 0 holders.
- The largest Aimei Health Technology Co Right buyer in Q1 2025 was UBS Group, an estimated $13.8K added.
- The largest Aimei Health Technology Co Right seller in Q1 2025 was Shaolin Capital Management, an estimated $16.7K sold.
Based on aggregated 13F filings for Q1 2025.